{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:29:30Z","timestamp":1793669370035,"version":"4.5.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.msard.2026.108003","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:40:41Z","timestamp":1792276841000},"page":"108003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras"],"prefix":"10.1016","volume":"116","author":[{"given":"Shou-Hui","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Huei","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ching","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tzu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5097-1206","authenticated-orcid":false,"given":"Syuan-Yu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msard.2026.108003_bib0001","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1007\/s00415-023-11737-8","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges","volume":"270","author":"Al-Ani","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.108003_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101944","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): insights into pathogenesis and biomarkers of prognosis","volume":"78","author":"Andersen","year":"2025","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2026.108003_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2023.06.009","article-title":"Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders","volume":"42","author":"Cacciaguerra","year":"2024","journal-title":"Neurol. Clin."},{"issue":"14","key":"10.1016\/j.msard.2026.108003_bib0005","first-page":"e1418","article-title":"Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder","volume":"100","author":"Cacciaguerra","year":"2023","journal-title":"Neurology"},{"issue":"10391","key":"10.1016\/j.msard.2026.108003_bib0008","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","article-title":"Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK","volume":"401","author":"Conrad","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.msard.2026.108003_bib0009","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1212\/WNL.0000000000201465","article-title":"Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging","volume":"100","author":"Cortese","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.108003_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100255","article-title":"Association of COVID-19 with thyroid dysfunction and autoimmune thyroid disease: A retrospective cohort study","volume":"9","author":"Di","year":"2024","journal-title":"J. Transl. Autoimmun."},{"issue":"Pt A","key":"10.1016\/j.msard.2026.108003_bib0011","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jad.2021.11.004","article-title":"Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization","volume":"298","author":"Heerlein","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.msard.2026.108003_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103286","article-title":"Impact of COVID-19 public health measures on myelin oligodendrocyte glycoprotein IgG-associated disorders in children","volume":"56","author":"Kaseka","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.108003_bib0013","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-023-06676-1","article-title":"Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD","volume":"44","author":"Kim","year":"2023","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2026.108003_bib0014","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1352458520933884","article-title":"Coexisting systemic and organ-specific autoimmunity in MOG-IgG1-associated disorders versus AQP4-IgG+ NMOSD","volume":"27","author":"Kunchok","year":"2021","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2026.108003_bib0015","first-page":"442","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0016","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00415-025-13303-w","article-title":"Characteristics of MRI lesions in AQP4 antibody-positive NMOSD, MOGAD, and multiple sclerosis: a systematic review and meta-analysis","volume":"272","author":"Leitner","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.108003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2025.110395","article-title":"Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches","volume":"256","author":"Li","year":"2025","journal-title":"Exp. Eye Res."},{"issue":"7","key":"10.1016\/j.msard.2026.108003_bib0018","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp-2025-336041","article-title":"Silent burden: recognising and managing invisible symptoms in neuromyelitis optica","volume":"96","author":"Lorefice","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.108003_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1516126","article-title":"A comprehensive review of methodologies and application to use the real-world data and analytics platform TriNetX","volume":"16","author":"Ludwig","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2026.108003_bib0020","doi-asserted-by":"crossref","DOI":"10.1177\/11795735231167869","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review","volume":"15","author":"Mirmosayyeb","year":"2023","journal-title":"J. Cent. Nerv. Syst. Dis."},{"issue":"3","key":"10.1016\/j.msard.2026.108003_bib0021","article-title":"Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a systematic review","volume":"8","author":"Molazadeh","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"4","key":"10.1016\/j.msard.2026.108003_bib0023","article-title":"Quantitative analysis of aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies titres: correlation with relapses","volume":"7","author":"Nasello","year":"2025","journal-title":"Brain Commun"},{"issue":"11","key":"10.1016\/j.msard.2026.108003_bib0024","article-title":"Decreased risk of recurrent acute pancreatitis with semaglutide and tirzepatide in people with type 2 diabetes or obesity with a history of acute pancreatitis: a propensity matched global federated TriNetX database-based retrospective cohort study","volume":"18","author":"Nassar","year":"2024","journal-title":"Diabetes Metab. Syndr."},{"issue":"4","key":"10.1016\/j.msard.2026.108003_bib0025","article-title":"COVID-19 in Patients With Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody Disease in North America: From the COVIMS Registry","volume":"8","author":"Newsome","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0026","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41597-022-01901-6","article-title":"COVID-Dynamic: A large-scale longitudinal study of socioemotional and behavioral change across the pandemic","volume":"10","author":"Rusch","year":"2023","journal-title":"Sci. Data."},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0027","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-025-13180-3","article-title":"The impact of autoimmune comorbidities on the onset attack recovery in adults with AQP4-NMOSD and MOGAD","volume":"272","author":"Samadzadeh","year":"2025","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0028","article-title":"Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort","volume":"32","author":"Samadzadeh","year":"2025","journal-title":"Eur. J. Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.108003_bib0029","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jaci.2024.12.1074","article-title":"Long COVID: pathophysiology, current concepts, and future directions","volume":"155","author":"Skevaki","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0030","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/s41598-024-83760-2","article-title":"Clinical characteristics of anti-myelin oligodendrocyte glycoprotein antibody among aquaporin-4 negative neuromyelitis optica spectrum disorders in Egyptian patients","volume":"15","author":"Taha","year":"2025","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.msard.2026.108003_bib0031","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","article-title":"Autoimmunity in long COVID","volume":"155","author":"Talwar","year":"2025","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.108003_bib0033","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200340","article-title":"Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease","volume":"12","author":"Villacieros-\u00c1lvarez","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.108003_bib0034","article-title":"Systemic inflammation response index is a useful indicator in distinguishing MOGAD from AQP4-IgG-positive NMOSD","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.108003_bib0035","article-title":"Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks","volume":"53","author":"Wang","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"2","key":"10.1016\/j.msard.2026.108003_bib0036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.msard.2026.108003_bib0037","first-page":"159","article-title":"Clinical features of neuromyelitis optica spectrum disorders with connective tissue diseases","volume":"43","author":"Xie","year":"2021","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.msard.2026.108003_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104003","article-title":"COVID-19 infection after two doses of SARS-CoV-2 mRNA vaccine in multiple sclerosis, AQP4-antibody NMOSD and MOGAD","volume":"65","author":"Yeo","year":"2022","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826010382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:11:22Z","timestamp":1793668282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826010382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S2211034826010382"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.108003","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune comorbidity profiles in MOGAD and AQP4-NMOSD: a real-world evidence study of top 10 autoimmune disorders across the pre- and post-COVID-19 eras","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.108003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108003"}}